Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Mixed Data for Fatty Acid Intake and Glaucoma

Mixed Data for Fatty Acid Intake and Glaucoma

Action Points

  • Note that this analysis of NHANEs data found weak evidence for links between dietary fatty acid intake and glaucoma prevalence.
  • While there may be some true effect, the use of dietary questionnaires to arrive at fatty acid intake is subject to significant biases that may add more noise to the data.

Consumption of polyunsaturated fatty acids (PUFAs) had mixed effects on the risk of glaucoma, data from a national survey showed.

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), members of the omega-3 group, had a protective effect whereas increased total consumption of PUFAs was associated with a higher risk of glaucoma. The apparent contradictory impact might have resulted from confounding factors, including the relative intake of omega-6 and omega-3 fatty acids and comorbid conditions, researchers said in JAMA Ophthalmology.

“This study also hypothesizes that increasing the proportion of dietary omega-3 consumption levels while controlling overall daily PUFA intake may be protective against glaucoma,” Anne L. Coleman, MD, PhD, of the UCLA David Geffen School of Medicine in Los Angeles, and co-authors concluded.

“Because a causal association between daily omega-3 fatty acid (or PUFA intake in general) and the risk of glaucoma could not be drawn in this observational study, additional longitudinal studies or randomized clinical trials are warranted to extend these findings. The role of the dietary consumption of omega-3 relative to omega-6 fatty acid levels also need further elucidation.”

Essential nutrients for human development and health, EPA and DHA occur in large concentrations in certain tissues, including the retina. Clinical studies showed reduced levels of omega-3 fatty acids in patients with glaucoma compared with individuals without the eye disease. Other clinical research showed a lower prevalence of glaucoma in people with a high intake ratio of omega-3 to omega-6 fatty acids.

To continue investigation of PUFAs and glaucoma, Coleman and colleagues analyzed data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES). Examinations performed during the 2005-2008 survey included a standard eye exam, visual field testing, and optic disc photography. A dietary component of the survey provided information about survey participants’ food consumption.

Data analysis included 3,865 NHANES participants ≥40 with complete nutrition interview, laboratory, eye-exam results (which, said the authors, translated to a weighted 83.6 million people in the general population). The primary outcome was prevalence of glaucoma, as defined by the Rotterdam criteria (a combination of optic nerve appearance and visual field defects), as determined by logistic regression analysis. The primary exposure was daily dietary PUFA consumption, estimated from survey participants’ dietary recall interviews and data from U.S. Department of Agriculture resources.

The analysis found a 3.7% prevalence of glaucoma. As compared with people who did not have glaucoma, the glaucoma subgroup was significantly older (mean age 61.4 versus 53.7, P<0.001) and had a higher proportion of non-Hispanic black individuals (23.0% versus 5.2%, P<0.001).

NHANES participants with glaucoma had significantly lower consumption of saturated fatty acids (23.60 versus 26.94 g, P=0.003) and numerically lower consumption of monounsaturated fatty acids (27.52 versus 30.05 g, P=0.07). Dietary consumption of PUFAs did not differ significantly between participants with and without glaucoma (17.22 versus 17.67, P=0.67).

Analysis of PUFA subtypes revealed small but statistically significant differences in consumption of EPA and DHA. The raw-data analysis showed that NHANES participants with glaucoma had mean daily EPA consumption of 8.54 mg compared with 8.50 mg for the participants without glaucoma (P=0.002). The glaucoma subgroup also consumed an average of 34.4 mg of DHA daily versus 33.8 mg for the participants without glaucoma (P=0.04).

However, logistic regression analysis, showed a significant association between mean daily dietary intake of EPA and DHA and a lower risk of glaucoma (OR 0.06, 95% CI 0.00 to 0.73 for EPA; OR 0.06, 95% CI 0.01 to 0.87 for DHA). Intake of other PUFAs assessed by NHANES neither increased nor decreased the risk of glaucoma.

Logistic regression analysis of total PUFA intake and glaucoma risk produced a different statistical picture. NHANES with total daily dietary PUFA intake in the second or third quartile had an increased likelihood of developing glaucoma (OR 2.84, 95% CI 1.39 to 5.79 for second quartile; OR 2.97, 95% CI 1.08 to 8.15 for third quartile), but participants with the highest total PUFA consumption did not have an increased risk of glaucoma (OR 2.03, 95% CI 0.74 to 5.52).

“This finding, although apparently contradicting our finding that increased consumption of EPA and DHA was associated with glaucoma, suggests that even though certain subtypes of PUFAs may reduce the risk of glaucoma, excess PUFA consumption may not,” the authors noted in the discussion of their findings. “Alternatively, the apparently discrepant finding may be secondarily associated with the ratio between omega-3 and omega-6 fatty acid intake.”

A previous large study showed an increased risk of glaucoma in individuals with an omega-3 to omega-6 intake ratio in the highest quintile, they added. The NHANES survey did not capture all omega-3 and omega-6 subtypes, precluding calculation of the ratio.

The authors disclosed no relevant relationships with industry.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles